Work

A novel effervescent formulation of oral weekly alendronate (70 mg) improves persistence compared to alendronate tablets in post-menopausal women with osteoporosis

Year: 2021

Type: article

Study design: Observational Study

Source: Aging Clinical and Experimental Research

DOI: 10.1007/s40520-020-01777-9

Authors: Andrea Giusti, Gerolamo Bianchi, Antonella Barone, Dennis M. Black

Institutions: Ente Ospedaliero Ospedali Galliera, University of California, San Francisco

Language: English

Topic: Medication Adherence and Compliance

Subfield: Family Practice

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3119246786

FWCI: 1.981

Cites: 44

Cited by: 9

Related to: 10